OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
Claudio Tirelli, Chiara Pesenti, Monica Miozzo, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3107-3107
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Lung regeneration: diverse cell types and the therapeutic potential
Yutian Chen, Zhen Li, Gaili Ji, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 11

The Genetic Basis, Lung Involvement, and Therapeutic Options in Niemann–Pick Disease: A Comprehensive Review
Claudio Tirelli, Ornella Rondinone, Marta Italia, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 211-211
Open Access | Times Cited: 8

Highlights on Future Treatments of IPF: Clues and Pitfalls
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 8

Exploring the Potential Role of Metabolomics in COPD: A Concise Review
Claudio Tirelli, Sabrina Mira, Luca Alessandro Belmonte, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 475-475
Open Access | Times Cited: 5

Central Role of CT in Management of Pulmonary Fibrosis
Kum Ju Chae, Hye Jeon Hwang, Rosane Duarte Achcar, et al.
Radiographics (2024) Vol. 44, Iss. 6
Closed Access | Times Cited: 5

Predictive biomarkers of disease progression in idiopathic pulmonary fibrosis
Weiwei Zhu, Chunquan Liu, Chunting Tan, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23543-e23543
Open Access | Times Cited: 12

DNA methylation modification in Idiopathic pulmonary fibrosis
Lu Ren, Yanfen Chang, Shi-He Jiang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4

Investigational gene expression inhibitors for the treatment of idiopathic pulmonary fibrosis
Paolo Spagnolo, Roberto Tonelli, Marco Mura, et al.
Expert Opinion on Investigational Drugs (2025), pp. 1-20
Closed Access

Advances in idiopathic pulmonary fibrosis diagnosis and treatment
Hongli Liu, Jiaxi Shen, Chao He
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2025) Vol. 3, Iss. 1, pp. 12-21
Open Access

Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma
Junzhi Liu, Huimin Li, Nannan Zhang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 25, pp. 4034-4055
Closed Access | Times Cited: 3

Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver disease
David E. Kaplan, Craig C. Teerlink, Tae‐Hwi Schwantes‐An, et al.
Hepatology Communications (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 3

Assessment and Management of Cough in Idiopathic Pulmonary Fibrosis: A Narrative Review
Shangxiang Liu, Xu Ye
Lung (2023) Vol. 201, Iss. 6, pp. 531-544
Closed Access | Times Cited: 4

Soybean Extract Ameliorates Lung Injury induced by Uranium Inhalation: An integrated strategy of network pharmacology, metabolomics, and transcriptomics
Xin Yang, Hongying Liang, Yufu Tang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117451-117451
Open Access | Times Cited: 1

Vascular involvement in idiopathic pulmonary fibrosis
Michele Mondoni, Rocco Francesco Rinaldo, Christopher J. Ryerson, et al.
ERJ Open Research (2024) Vol. 10, Iss. 6, pp. 00550-2024
Open Access | Times Cited: 1

TANGO1 Dances to Export of Procollagen from the Endoplasmic Reticulum
Carol M. Artlett, Lianne M. Connolly
Deleted Journal (2023) Vol. 1, Iss. 2, pp. 10008-10008
Open Access | Times Cited: 3

Idiopathic Pulmonary Fibrosis: 8 Years On After Nintedanib and Pirfenidone Approval—What Is on the Horizon?
G. Castelli, Elisabetta Cocconcelli, Nicol Bernardinello, et al.
Current Pulmonology Reports (2023) Vol. 12, Iss. 3, pp. 113-124
Closed Access | Times Cited: 2

Genome and Transcriptome-Wide Association Study of Fibrotic Sarcoidosis in European Americans
Shu‐Yi Liao, Lisa A. Maier, Tasha E. Fingerlin
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 209, Iss. 3, pp. 334-337
Closed Access | Times Cited: 2

Histopathological findings in lung biopsies with usual interstitial pneumonia: Definition of a new classification score for histological fibrotic stages
Mária Makovická, A Vrbenská, Peter J. Makovicky, et al.
General Physiology and Biophysics (2024) Vol. 43, Iss. 01, pp. 49-56
Open Access

Identification of non-coding RNA signatures in idiopathic pulmonary fibrosis
Alperen Elek, Esra Bozgeyik, Halil Caska, et al.
Irish Journal of Medical Science (1971 -) (2024) Vol. 193, Iss. 4, pp. 1923-1927
Closed Access

Integrated multiomic analysis identifiesTRIP13as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis
Laurence St. Pierre, Asres Berhan, Eun Kyu Sung, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
Fabio Perrotta, Stefano Sanduzzi Zamparelli, Vito D’Agnano, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1384-1384
Open Access

Page 1 - Next Page

Scroll to top